CITIZEN CPR FOUNDATION BRINGS THE ENTIRE CHAIN OF SUDDEN CARDIAC ARREST SURVIVAL TO SEATTLE, WA
December 04, 2019 14:42 ET
|
Citizen CPR Foundation
Overland Park, Kansas, Dec. 04, 2019 (GLOBE NEWSWIRE) -- The Citizen CPR Foundation will host the first Cardiac Arrest Survival Summit in Seattle, Washington December 10th through 13th at the Hyatt...
Biotricity Completes Development of its ECG Patch Platform
December 04, 2019 08:00 ET
|
biotricity
REDWOOD CITY, Calif., Dec. 04, 2019 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB: BTCY), a medical diagnostic and consumer healthcare technology company, today announced that it has completed...
CITIZEN CPR FOUNDATION BECOMES A CATALYST AND RESOURCE FOR ACTION TO IMPROVE CARDIAC ARREST SURVIVAL RATES
August 01, 2019 11:42 ET
|
Citizen CPR Foundation
Overland Park, Kansas, Aug. 01, 2019 (GLOBE NEWSWIRE) -- The Citizen CPR Foundation (CCPRF) today announced visionary new strategies designed to move the needle on sudden cardiac arrest (SCA)...
InCarda Therapeutics Appoints Daniel G. Welch as Executive Chairman of Board of Directors
April 03, 2019 08:00 ET
|
InCarda Therapeutics, Inc.
SAN FRANCISCO, April 03, 2019 (GLOBE NEWSWIRE) -- InCarda Therapeutics, Inc. (“InCarda”), a privately-held biopharmaceutical company developing first-of-their-kind inhaled therapies for...
New Patent Issuances Strengthen InCarda Therapeutics’ Intellectual Property Portfolio Covering Novel Inhaled Cardiovascular Therapies
February 07, 2019 08:05 ET
|
InCarda Therapeutics, Inc.
U.S. Patent Broadly Expands Coverage for Inhaled Treatment of Cardiovascular Disease to Include all Class I – IV Antiarrhythmic Drugs Additional U.S. Patent Provides Coverage for Combination of...
3Scan Selected for Crucial efforts in NIH SPARC Initiative
December 07, 2018 10:04 ET
|
3Scan
San Francisco, Dec. 07, 2018 (GLOBE NEWSWIRE) -- 3Scan, Inc. (3Scan), the world’s leading 3D tissue imaging company has been contracted to provide crucial data in a multi-scale, multi-disciplinary...
BioSig Technologies to Present at the 8th Annual LD Micro Invitational
June 01, 2018 12:55 ET
|
BioSig Technologies, Inc.
Santa Monica, CA, June 01, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical technology company developing a proprietary biomedical signal processing platform designed to...
BioSig Technologies Completes Private Placement
May 01, 2018 08:00 ET
|
BioSig Technologies, Inc.
Santa Monica, CA, May 01, 2018 (GLOBE NEWSWIRE) --
BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed...
BioSig Announces Submission of FDA 510(k) Application for PURE EP™ System
March 28, 2018 02:00 ET
|
BioSig Technologies, Inc.
SANTA MONICA, Calif., March 28, 2018 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB:BSGM) announced that the Company has filed 510(k) application to the U.S. Food and Drug Administration (FDA)...
BioSig Technologies to Open Operations Center in Austin, Texas
February 13, 2018 08:00 ET
|
BioSig Technologies, Inc.
Santa Monica, CA, Feb. 13, 2018 (GLOBE NEWSWIRE) --
BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary biomedical signal processing platform...